Potential Impact of Vaginal Microbicides on HIV Risk Among Women With Primary Heterosexual Partners

References 

1. Alliance for Microbicide Development. (2009). Microbicide pipeline update. Retrieved from http://www.microbicide.org
2. Boily MC, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, et al. Heterosexual risk of HIV-1 infection per sexual act: Systematic review and meta-analysis of observational studies. Lancet Infectious Diseases. 2009;9:118–129
3. Conley TD, Collins BE. Differences between condom users and condom nonusers in their multidimensional condom attitudes. Journal of Applied Social Psychology. 2005;35:603–620
4. Darroch JE, Frost JJ. Women's interest in vaginal microbicides. Family Planning Perspectives. 1999;31:16–23
   • MEDLINE
   • CrossRef
5. Dowling-Guyer S, Johnson ME, Fisher DG, Needle R, Watters J, Andersen M, et al. Reliability of drug users' self-reported HIV risk behaviors and validity of self reported recent drug use. Assessment. 1994;1:383–392
6. Foss AM, Vickerman PT, Heise L, Watts CH. Shifts in condom use following microbicide introduction: Should we be concerned?. AIDS. 2003;17:1227–1237
   • MEDLINE
   • CrossRef
7. Higgins JA, Hoffman S, Dworkin SL. Rethinking gender, heterosexual men, and women's vulnerability to HIV/AIDS. American Journal of Public Health. 2010;100:435–445
   • CrossRef
8. Joint United Nations Programme on HIV/AIDS. (2004). 2004 report on the global AIDS epidemic. Retrieved from http://www.unaids.org/bangkok2004/GAR2004_pdf/UNAIDSGlobalReport2004_en.pdf
9. Kaler A. The future of female controlled barrier methods for HIV prevention: Female condoms and lessons learned. Culture, Health & Sexuality. 2004;6:501–516
10. Kalichman SC, Rompa D, Luke W, Austin J. HIV transmission risk behaviours among HIV-positive persons in serodiscordant relationships. International Journal of STD & AIDS. 2002;13:677–682
11. Karmon E, Potts M, Getz WM. Microbicides and HIV: Help or hindrance?. Journal of Acquired Immune Deficiency Syndromes. 2003;34:71–75
12. Mastro TD, Kitayaporn D. HIV type 1 transmission probabilities: Estimates from epidemiological studies. AIDS Research and Human Retroviruses. 1998;14(Suppl 3):S223–S227
13. McGowan I. Microbicide for HIV prevention: Reality or hope?. Current Opinions in Infectious Diseases. 2010;23:26–31
14. McMahon, J.M., Tortu, S., Pouget, E.R., Hamid, R., & Torres, L. (2004). Increased sexual risk behavior and high HIV seroincidence among drug-using low-income women with primary heterosexual partners [abstract]. Presented at the XV International AIDS Conference, Bangkok, Thailand. Retrieved from http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102282096.html
15. Morris GC, Lacey CJ. Microbicides and HIV prevention: Lessons from the past, looking to the future. Current Opinions in Infectious Diseases. 2010;23:57–63
16. O'Leary A. Women at risk for HIV from a primary partner: Balancing risk and intimacy. Annual Review of Sex Research. 2000;11:191–234
    • MEDLINE
17. Padian NS, Shiboski SC, Jewell NP. Female-to-male transmission of human immunodeficiency virus. Journal of the American Medical Association. 1991;266:1664–1667
18. Quinn TC, Overbaugh J. HIV/AIDS in women: An expanding epidemic. Science. 2005;308:1582–1583
    • CrossRef
19. Ramjee G, Morar NS, Braunstein S, Friedland B, Jones H, van de Wijgert J. Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa. AIDS Research and Therapy. 2007;4:20
20. Remien RH, Halkitis PN, O'Leary A, Wolitski RJ, Gomez CA. Risk perception and sexual risk behaviors among HIV-positive men on antiretroviral therapy. AIDS and Behavior. 2005;9:167–176
    • MEDLINE
    • CrossRef
21. Short MB, Rosenthal SL, Auslander BA, Succop PA. Relationship context associated with microbicide-like product use. Journal of Pediatric and Adolescent Gynecology. 2009;22:313–317
    • Abstract
    • Full Text
    • Full-Text PDF (76 KB)
    • CrossRef
22. Smith RJ, Bodine EN, Wilson DP, Blower SM. Evaluating the potential impact of vaginal microbicides to reduce the risk of acquiring HIV in female sex workers. AIDS. 2005;19:413–421
    • MEDLINE
23. Terris-Prestholt, F., Kumaranayake, L., MacPhail, C., Rees, H., & Watts, C. (2007). Women's willingness to pay for barrier methods for HIV prevention in South Africa: A comparison of the female condom, diaphragm, and microbicides. [abstract]. iHEA 2007 6th World Congress: Copenhagen, Denmark. Explorations in Health Economics Paper. Retrieved from http://ssrn.com/abstract=993517.
24. Watts, C.H. (2002). The public health impact of microbicides: Model projections. Retrieved from http://www.itg.be/micro2002/Pages/Abstracts.html
25. Wilson, D.P., Coplan, P.M., Wainberg, M.A., & Blower, S.M. (2008). The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics. Proceedings of the National Academy of Sciences of the United States of America, 105, 9835–9840. doi:10.1073/pnas.0900163106
26. van de Wijgert J, Coggins C. Microbicides to prevent heterosexual transmission of HIV: Ten years down the road. Bulletin of Experimental Treatments for AIDS. 2002;15:23–28Retrieved from http://pdf.usaid.gov/pdf_docs/PNACW226.pdf
27. van der Straten A, Gomez CA, Saul J, Quan J, Padian N. Sexual risk behaviors among heterosexual HIV serodiscordant couples in the era of post-exposure prevention and viral suppressive therapy. AIDS. 2000;14:F47–F54
    • MEDLINE
    • CrossRef